Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROCEED: Delafloxacin vs Vancomycin/Aztreonam in ABSSSI
NCT01811732Phase 3Completed
- Sponsor
- Melinta Therapeutics
- Start
- Apr 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of delafloxacin in acute bacterial skin and skin structure infections (ABSSSI), sponsored by Melinta Therapeutics. Started Apr 2013; status: completed.
02
Drugs
delafloxacin
03
Conditions
acute bacterial skin and skin structure infections (ABSSSI)
Beyond the preview
Go deeper on NCT01811732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01811732.